WallStreetZenWallStreetZen

NASDAQ: CLRB
Cellectar Biosciences Inc Stock Ownership - Who owns Cellectar Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cellectar Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jarrod LongcorChief Operating Officer2025-01-1030,000$0.28
$8.40kBuy

1 of 1

CLRB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLRB insiders and whales buy or sell their stock.

CLRB Shareholders

What type of owners hold Cellectar Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc3.75%1,727,001$511.19kInstitution
Austin W. Greenhouse David M. Marxe2.48%1,142,368$338.14kInsider
John Neis2.15%989,818$292.99kInsider
Adar1 Capital Management LLC1.27%585,261$173.24kInstitution
Cormorant Asset Management LP1.15%530,000$156.88kInsider
Squarepoint Ops LLC1.13%520,240$153.99kInstitution
Alumni Research Foundation Wisconsin1.02%469,484$138.97kInsider
Ubs Group Ag0.82%376,199$111.35kInstitution
Geode Capital Management LLC0.76%350,885$103.86kInstitution
Richard Hertzberg0.61%280,000$82.88kInsider

1 of 3

CLRB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLRB11.06%8.96%Net Buying
BOLT48.33%51.67%
SYBX5.61%94.39%Net SellingNet Selling
MEIP15.70%84.30%Net Buying
KAPA2.44%40.42%Net Buying
View Top Biotech Stocks

Cellectar Biosciences Stock Ownership FAQ

Who owns Cellectar Biosciences?

Cellectar Biosciences (NASDAQ: CLRB) is owned by 11.06% institutional shareholders, 8.96% Cellectar Biosciences insiders, and 79.98% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Cellectar Biosciences shareholder, owning 1.14M shares representing 2.48% of the company. Austin W. Greenhouse David M. Marxe's Cellectar Biosciences shares are currently valued at $332.43k.

If you're new to stock investing, here's how to buy Cellectar Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.